The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
Open accessAbstract
Tumors escape immunological rejection by a diversity of mechanisms. In this report, we demonstrate that the colon cancer cell SW620 expresses functional Fas ligand (FasL), the triggering agent of Fas receptor (FasR)-mediated apoptosis within the immune system. FasL mRNA and cell surface FasL were detected in SW620 cells using reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemical staining, respectively. We show that SW620 kills Jurkat T cells in a Fas-mediated manner. FasR-specific antisense oligonucleotide treatment, which transiently inhibited FasR expression, completely protected Jurkat cells from killing by SW620. FasL-specific antisense oligonucleotide treatment of SW620 inhibited its Jurkat-killing activity. FasL has recently been established as a mediator of immune privilege in mouse retina and testis. Our finding that colon cancer cells express functional FasL suggests it may play an analogous role in bestowing immune privilege on human tumors. HT29 and SW620 colon cancer cells were found to express FasR mRNA and cell surface FasR using RT-PCR and immunofluorescence flow cytometry, respectively. However, neither of these cells underwent apoptosis after treatment by the anti-FasR agonistic monoclonal antibody CH11. Our results therefore suggest a Fas counterattack model for immune escape in colon cancer, whereby the cancer cells resist Fas-mediated T cell cytotoxicity but express functional FasL, an apoptotic death signal to which activated T cells are inherently sensitive.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y., & Nagata, S. (1991) · Cell · doi:10.1016/0092-8674(91)90614-5 · Cited by 2,737
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005
Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middelton, L. A., Lin, A. Y., Strober, W., Lenardo, M. J., & Puck, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90013-6 · Cited by 1,465
Mutations in Fas Associated with Human Lymphoproliferative Syndrome and Autoimmunity
Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I. A. G., Debatin, K. M., Fischer, A., & de Villartay, J. P. (1995) · Science · doi:10.1126/science.7539157 · Cited by 1,297
A role for CD95 ligand in preventing graft rejection
Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A., & Duke, R. C. (1995) · Nature · doi:10.1038/377630a0 · Cited by 1,155
Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas Molecule
Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., & Mountz, J. D. (1994) · Science · doi:10.1126/science.7510905 · Cited by 1,107
Fas ligand mediates activation-induced cell death in human T lymphocytes.
Alderson, M. R., Tough, T. W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F., & Lynch, D. H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.71 · Cited by 934
Fas and Fas ligand: lpr and gld mutations
Nagata, S., & Suda, T. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80069-7 · Cited by 892
Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expression
Owen-Schaub, L. B., Zhang, W., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A. B., Zhang, W.-W., Kruzel, E., et al. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3032 · Cited by 734
Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., et al. (1996) · Nature Medicine · doi:10.1038/nm0396-317 · Cited by 666
The JAM test A simple assay for DNA fragmentation and cell death
Matzinger, P. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90325-a · Cited by 599
Effect of bcl-2 on Fas antigen-mediated cell death.
Itoh, N., Tsujimoto, Y., & Nagata, S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.2.621 · Cited by 428
Cascino, I., Fiucci, G., Papoff, G., & Ruberti, G. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.6.2706 · Cited by 397
Weller, M., Frei, K., Groscurth, P., Krammer, P. H., Yonekawa, Y., & Fontana, A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117462 · Cited by 345
Ju, S. T., Cui, H., Panka, D. J., Ettinger, R., & Marshak-Rothstein, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4185 · Cited by 296
Jäättelä, M., Benedict, M., Tewari, M., Ja, S., & Dixit, V. (1995) · PubMed · Cited by 289
Owen‐Schaub, L. B., Radinsky, R., Kruzel, E., Berry, K. K., & Yonehara, S. (1994) · PubMed · Cited by 258
Weller, M., Malipiero, U., Aguzzi, A., Reed, J. C., & Fontana, A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117965 · Cited by 250
Autoimmune disease. a problem of defective apoptosis
Mountz, J. D., Wu, J., Cheng, J., & Zhou, T. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371002 · Cited by 223
Inhibition of apoptosis as a mechanism of tumor promotion
Wright, S. C., Zhong, J., & Larrick, J. W. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.9.8005393 · Cited by 195
Nicotine inhibition of apoptosis suggests a role in tumor promotion
Wright, S. C., Zhong, J., Zheng, H., & Larrick, J. W. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.11.8370474 · Cited by 182
Fas Antigen-Mediated Apoptosis in Human Granulosa/luteal Cells1
Quirk, S. M., Cowan, R. G., Joshi, S. G., & Henrikson, K. P. (1995) · Biology of Reproduction · doi:10.1095/biolreprod52.2.279 · Cited by 182
Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells.
Daniel, P. T., & Krammer, P. H. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.12.5624 · Cited by 176
Sayama, K., Yonehara, S., Watanabe, Y., & Miki, Y. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12394858 · Cited by 171
Capaccioli, S., Dipasquale, G., Mini, E., Mazzei, T., & Quattrone, A. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2552 · Cited by 170
Yoshino, T., Kondo, E., Cao, L., Takahashi, K., Hayashi, K., Nomura, S., & Akagi, T. (1994) · Blood · doi:10.1182/blood.v83.7.1856.1856 · Cited by 133
Shima, Y., Nishimoto, N., Ogata, A., Fujii, Y., Yoshizaki, K., & Kishimoto, T. (1995) · Blood · doi:10.1182/blood.v85.3.757.bloodjournal853757 · Cited by 128
Fas/APO-1 gene transfer for human malignant glioma.
Weller, M., Malipiero, U., Rensing‐Ehl, A., Barr, P. J., & Fontana, A. (1995) · PubMed · Cited by 126
Inhibition of Apoptosis in T Cells Expressing Human T Cell Leukemia Virus Type I Tax
Copeland, K. F. T., Haaksma, A. G. M., Goudsmit, J., Krammer, P. H., & Heeney, J. L. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.1259 · Cited by 108
Matsue, H., Kobayashi, H., Hosokawa, T., Akitaya, T., & Ohkawara, A. (1995) · Archives of Dermatological Research · doi:10.1007/bf01105085 · Cited by 69
O'Mahony, A. M., O’Sullivan, G. C., O’Connell, J., Cotter, T. G., & Collins, J. K. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.9.4847 · Cited by 68
Self-citationBiosynthesis and shedding of murine lymphoma gangliosides
Li, R., Gage, D. A., & Ladisch, S. (1993) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(93)90011-w · Cited by 30
Gangliosides and antitumor immunity
Bergelson, L. D. (1993) · Journal of Molecular Medicine · doi:10.1007/bf00184480 · Cited by 20
Yagita, M., Seppo, A., Renkonen, O., & SAKSELA, E. (1993) · PubMed · Cited by 15
Cited by
Cell Membrane Coating Nanotechnology
Fang, R. H., Kroll, A. V., Gao, W., & Zhang, L. (2018) · Advanced Materials · doi:10.1002/adma.201706759 · Cited by 1,885
Role of tumor microenvironment in tumorigenesis
Wang, M., Zhao, J., Zhang, L., Wei, F., Lian, Y., Wu, Y., Gong, Z., Zhang, S., Zhou, J., Cao, K., et al. (2017) · Journal of Cancer · doi:10.7150/jca.17648 · Cited by 1,404
Jass, J. R. (2007) · Histopathology · doi:10.1111/j.1365-2559.2006.02549.x · Cited by 1,384
Reed, J. C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64779-7 · Cited by 1,288
Marincola, F. M., Jaffee, E. M., Hicklin, D. J., & Ferrone, S. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60911-6 · Cited by 1,174
Metadata
- Authors
- O'Connell, J., O'Sullivan, G. C., Collins, J. K., & Shanahan, F.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1996-09-01
- Volume
- 184
- Issue
- 3
- Pages
- 1075-1082
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2168747001
- Cited by
- 878
- References
- 35
- FWCI
- 28.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.